JPRN-UMIN000003451已完成未知
Renoprotective effects of azelnidipine in hypertensive diabetic patients in Mie - RANDAM
Komono Kosei Hospital0 个研究点目标入组 146 人开始时间: 2010年4月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 146
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria are: secondary hypertension; history of acute coronary syndrome, heart failure, coronary revascularization, or stroke within the previous 6 months; uncontrolled diabetes mellitus (HbA1c >9.0%); a disorder that requires treatment with calcium channel blockers or diuretics; confirmed or suspected renal artery stenosis; serum creatinine of 2.0mg/dl or more for men and 1.5mg/dl or more for women; pregnant women; or clinic systolic blood pressure >180mmHg and/or diastolic blood pressure >110mmHg.
研究者
相似试验
已完成
不适用
The influence of azelnidipine on plasma renin activity and plasma aldosterone concentration in hypertensive patients.JPRN-UMIN000001739Graduate School of Medical Sciences, Kumamoto University40
尚未招募
不适用
Study on Renoprotective effect of cilnidipine and amlodipine along with telmisartan in patients with type-2 diabetes and hypertensioCTRI/2024/04/065259Sri Ramaswamy Memorial
已完成
不适用
Influence of azelnidipine or Amlodipine on renal function and renin-angiotensin-aldosterone systemafter cardiac surgerymyocardial infarction, angina, valve disease, aortic dissectionJPRN-UMIN000001638ihon University Itabashi Hospital100
已完成
不适用
Influence of Olmesartan and azelnidipine on renal function during cardiac surgerymyocardial infarction, angina, aortic dessection, valve diseaseJPRN-UMIN000001637ihon University Itabashi Hospital100
已完成
不适用
AZELNIDIPINE COMBINED WITH ANGIOTENSIN RECEPTOR BLOCKER CAN RESTORE SYMPATHETIC ACTIVITYChronic Kidney Disease (CKD)JPRN-UMIN000009158Division of Nephrology, Nafoya City University Hospital20